LINDEN ADVISORS LP - CARDIO DIAGNOSTICS HOLDGS IN ownership

Back to all holdings Add to watchlist

CARDIO DIAGNOSTICS HOLDGS IN's ticker is and the CUSIP is 14159C103. A total of 16 filers reported holding CARDIO DIAGNOSTICS HOLDGS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of CARDIO DIAGNOSTICS HOLDGS IN
ValueSharesWeighting
Q3 2023$15,510
-71.4%
45,6180.0%0.00%
-100.0%
Q2 2023$54,285
-83.8%
45,618
-46.8%
0.00%
-75.0%
Q1 2023$335,138
+252.3%
85,7130.0%0.00%
+300.0%
Q4 2022$95,141–85,713–0.00%–
 Download
Other shareholders
CARDIO DIAGNOSTICS HOLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
PRELUDE CAPITAL MANAGEMENT, LLC 121,000$41,1400.00%
CALDWELL SUTTER CAPITAL, INC. 8,101$2,7540.00%
UBS Group AG 61$210.00%
PNC FINANCIAL SERVICES GROUP, INC. 40,500$13,7700.00%
WELLS FARGO & COMPANY/MN 47$160.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 75,483$25,6640.00%
STATE STREET CORP 20,100$6,8340.00%
LINDEN ADVISORS LP 45,618$15,5100.00%
WOLVERINE ASSET MANAGEMENT LLC 4,788$1,6270.00%
View complete list of CARDIO DIAGNOSTICS HOLDGS IN shareholders